Saturday, July 11, 2026

biotech · Relapsed or Refractory Multiple Myeloma

Wuhan YZY Biopharma

Wuhan YZY Biopharma clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Wuhan, CN HQ
2010 Founded
55 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Wuhan, CN
Founded
2010
Employees
55
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Programs

Wuhan YZY Biopharma projects

0 ClinicalTrials.gov programs sponsored by Wuhan YZY Biopharma.

Wuhan YZY Biopharma has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Wuhan YZY Biopharma have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.